Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Cash from Operations (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Cash from Operations for 3 consecutive years, with 14800000.0 as the latest value for Q4 2025.

  • For Q4 2025, Cash from Operations fell 1.02% year-over-year to 14800000.0; the TTM value through Dec 2025 reached 76800000.0, down 39.56%, while the annual FY2025 figure was 76800000.0, 39.56% down from the prior year.
  • Cash from Operations hit 14800000.0 in Q4 2025 for Artiva Biotherapeutics, up from 19200000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 10675000.0 in Q4 2023 and bottomed at 23000000.0 in Q2 2025.
  • Average Cash from Operations over 3 years is 15325500.0, with a median of 14725000.0 recorded in 2024.
  • On a YoY basis, Cash from Operations climbed as much as 1.02% in 2025 and fell as far as 68.07% in 2025.
  • Artiva Biotherapeutics' Cash from Operations stood at 10675000.0 in 2023, then plummeted by 37.24% to 14650000.0 in 2024, then decreased by 1.02% to 14800000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 14800000.0, 19200000.0, and 23000000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.